358 related articles for article (PubMed ID: 22750904)
1. Malnutrition and chemotherapy-induced nausea and vomiting: implications for practice.
Davidson W; Teleni L; Muller J; Ferguson M; McCarthy AL; Vick J; Isenring E
Oncol Nurs Forum; 2012 Jul; 39(4):E340-5. PubMed ID: 22750904
[TBL] [Abstract][Full Text] [Related]
2. The nurse's role in managing chemotherapy-induced nausea and vomiting: an international survey.
Krishnasamy M; Kwok-Wei So W; Yates P; de Calvo LE; Annab R; Wisniewski T; Aranda S
Cancer Nurs; 2014; 37(4):E27-35. PubMed ID: 24145248
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study.
Molassiotis A; Aapro M; Dicato M; Gascon P; Novoa SA; Isambert N; Burke TA; Gu A; Roila F
J Pain Symptom Manage; 2014 May; 47(5):839-848.e4. PubMed ID: 24075401
[TBL] [Abstract][Full Text] [Related]
4. Effect of concord grape juice on chemotherapy-induced nausea and vomiting: results of a pilot study.
Ingersoll GL; Wasilewski A; Haller M; Pandya K; Bennett J; He H; Hoffmire C; Berry C
Oncol Nurs Forum; 2010 Mar; 37(2):213-21. PubMed ID: 20189927
[TBL] [Abstract][Full Text] [Related]
5. Knowledge and practice among Hong Kong oncology nurses in the management of chemotherapy-induced nausea and vomiting.
So WK; Chan DN; Chan HY; Krishnasamy M; Chan T; Ling WM; Lo JC; Aranda S
Eur J Oncol Nurs; 2013 Jun; 17(3):370-4. PubMed ID: 23153452
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced nausea and vomiting and antiemetic prophylaxis with palonosetron versus other 5-HT3 receptor antagonists in patients with cancer treated with low emetogenic chemotherapy in a hospital outpatient setting in the United States.
Schwartzberg L; Morrow G; Balu S; Craver C; Gayle J; Cox D
Curr Med Res Opin; 2011 Aug; 27(8):1613-22. PubMed ID: 21696263
[TBL] [Abstract][Full Text] [Related]
7. Nutritional status and dietary intake of acute care patients: results from the Nutrition Care Day Survey 2010.
Agarwal E; Ferguson M; Banks M; Bauer J; Capra S; Isenring E
Clin Nutr; 2012 Feb; 31(1):41-7. PubMed ID: 21862187
[TBL] [Abstract][Full Text] [Related]
8. Optimizing treatment outcomes in patients at risk for chemotherapy-induced nausea and vomiting.
Thompson N
Clin J Oncol Nurs; 2012 Jun; 16(3):309-13. PubMed ID: 22641323
[TBL] [Abstract][Full Text] [Related]
9. A nurse-led evidence-based practice project to monitor and improve the management of chemotherapy-induced nausea and vomiting.
Underhill ML; Chicko L; Berry DL
Clin J Oncol Nurs; 2015 Feb; 19(1):38-40. PubMed ID: 25689647
[TBL] [Abstract][Full Text] [Related]
10. Palonosetron versus other 5-HT(3) receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with cancer on chemotherapy in a hospital outpatient setting.
Balu S; Buchner D; Craver C; Gayle J
Clin Ther; 2011 Apr; 33(4):443-55. PubMed ID: 21635990
[TBL] [Abstract][Full Text] [Related]
11. Delayed nausea and vomiting continue to reduce patients' quality of life after highly and moderately emetogenic chemotherapy despite antiemetic treatment.
Bloechl-Daum B; Deuson RR; Mavros P; Hansen M; Herrstedt J
J Clin Oncol; 2006 Sep; 24(27):4472-8. PubMed ID: 16983116
[TBL] [Abstract][Full Text] [Related]
12. Palonosetron versus other 5-HT₃ receptor antagonists for prevention of chemotherapy-induced nausea and vomiting in patients with hematologic malignancies treated with emetogenic chemotherapy in a hospital outpatient setting in the United States.
Craver C; Gayle J; Balu S; Buchner D
J Med Econ; 2011; 14(3):341-9. PubMed ID: 21542674
[TBL] [Abstract][Full Text] [Related]
13. Prospective validation of a prediction tool for identifying patients at high risk for chemotherapy-induced nausea and vomiting.
Dranitsaris G; Bouganim N; Milano C; Vandermeer L; Dent S; Wheatley-Price P; Laporte J; Oxborough KA; Clemons M
J Support Oncol; 2013 Mar; 11(1):14-21. PubMed ID: 22763232
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy-induced nausea and vomiting: challenges and opportunities for improved patient outcomes.
Hawkins R; Grunberg S
Clin J Oncol Nurs; 2009 Feb; 13(1):54-64. PubMed ID: 19193549
[TBL] [Abstract][Full Text] [Related]
15. The effects of P6 acupressure and nurse-provided counseling on chemotherapy-induced nausea and vomiting in patients with breast cancer.
Suh EE
Oncol Nurs Forum; 2012 Jan; 39(1):E1-9. PubMed ID: 22201663
[TBL] [Abstract][Full Text] [Related]
16. Nausea and vomiting perspectives among children receiving moderate to highly emetogenic chemotherapy treatment.
Rodgers C; Kollar D; Taylor O; Bryant R; Crockett K; Gregurich MA; Hockenberry M
Cancer Nurs; 2012; 35(3):203-10. PubMed ID: 21915041
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy-Induced Nausea and Vomiting: A Narrative Review to Inform Dietetics Practice.
Marx W; Kiss N; McCarthy AL; McKavanagh D; Isenring L
J Acad Nutr Diet; 2016 May; 116(5):819-27. PubMed ID: 26686816
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of anti-emetic use in chemotherapy-induced nausea and vomiting in a third-world country (Lebanon).
Zeitoun AA; Nassif JG
J Eval Clin Pract; 2013 Feb; 19(1):68-75. PubMed ID: 21999252
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and cost: avoiding undertreatment of chemotherapy-induced nausea and vomiting.
Viale PH; Grande C; Moore S
Clin J Oncol Nurs; 2012 Aug; 16(4):E133-41. PubMed ID: 22842698
[TBL] [Abstract][Full Text] [Related]
20. Chemotherapy-induced nausea and vomiting: incidence and impact on patient quality of life at community oncology settings.
Cohen L; de Moor CA; Eisenberg P; Ming EE; Hu H
Support Care Cancer; 2007 May; 15(5):497-503. PubMed ID: 17103197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
